Neurofilament light chain (NfL) is a specific biomarker of neuro-axonal damage. Matrix metalloproteinases (MMPs) are zinc-dependent enzymes involved in blood-brain barrier (BBB) integrity. We explored neuro-axonal damage, alteration of BBB integrity and SARS-CoV-2 RNA presence in COVID-19 patients with severe neurological symptoms (neuro-COVID) as well as neuro-axonal damage in COVID-19 patients without severe neurological symptoms according to disease severity and after recovery, comparing the obtained findings with healthy donors (HD). Overall, COVID-19 patients (n = 55) showed higher plasma NfL levels compared to HD (n = 31) (p < 0.0001), especially those who developed ARDS (n = 28) (p = 0.0005). After recovery, plasma NfL levels were still higher in ARDS patients compared to HD (p = 0.0037). In neuro-COVID patients (n = 12), higher CSF and plasma NfL, and CSF MMP-2 levels in ARDS than non-ARDS group were observed (p = 0.0357, p = 0.0346 and p = 0.0303, respectively). SARS-CoV-2 RNA was detected in four CSF and two plasma samples. SARS-CoV-2 RNA detection was not associated to increased CSF NfL and MMP levels. During COVID-19, ARDS could be associated to CNS damage and alteration of BBB integrity in the absence of SARS-CoV-2 RNA detection in CSF or blood. CNS damage was still detectable after discharge in blood of COVID-19 patients who developed ARDS during hospitalization.

Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients / Zingaropoli, Maria Antonella; Iannetta, Marco; Piermatteo, Lorenzo; Pasculli, Patrizia; Latronico, Tiziana; Mazzuti, Laura; Campogiani, Laura; Duca, Leonardo; Ferraguti, Giampiero; De Michele, Manuela; Galardo, Gioacchino; Pugliese, Francesco; Antonelli, Guido; Andreoni, Massimo; Sarmati, Loredana; Lichtner, Miriam; Turriziani, Ombretta; Ceccherini-Silberstein, Francesca; Liuzzi, Grazia Maria; Mastroianni, Claudio Maria; Ciardi, Maria Rosa. - In: CELLS. - ISSN 2073-4409. - 11:16(2022), pp. 1-18. [10.3390/cells11162480]

Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients

Zingaropoli, Maria Antonella
;
Pasculli, Patrizia;Mazzuti, Laura;Campogiani, Laura;Ferraguti, Giampiero;De Michele, Manuela;Galardo, Gioacchino;Pugliese, Francesco;Antonelli, Guido;Andreoni, Massimo;Lichtner, Miriam;Turriziani, Ombretta;Mastroianni, Claudio Maria;Ciardi, Maria Rosa
2022

Abstract

Neurofilament light chain (NfL) is a specific biomarker of neuro-axonal damage. Matrix metalloproteinases (MMPs) are zinc-dependent enzymes involved in blood-brain barrier (BBB) integrity. We explored neuro-axonal damage, alteration of BBB integrity and SARS-CoV-2 RNA presence in COVID-19 patients with severe neurological symptoms (neuro-COVID) as well as neuro-axonal damage in COVID-19 patients without severe neurological symptoms according to disease severity and after recovery, comparing the obtained findings with healthy donors (HD). Overall, COVID-19 patients (n = 55) showed higher plasma NfL levels compared to HD (n = 31) (p < 0.0001), especially those who developed ARDS (n = 28) (p = 0.0005). After recovery, plasma NfL levels were still higher in ARDS patients compared to HD (p = 0.0037). In neuro-COVID patients (n = 12), higher CSF and plasma NfL, and CSF MMP-2 levels in ARDS than non-ARDS group were observed (p = 0.0357, p = 0.0346 and p = 0.0303, respectively). SARS-CoV-2 RNA was detected in four CSF and two plasma samples. SARS-CoV-2 RNA detection was not associated to increased CSF NfL and MMP levels. During COVID-19, ARDS could be associated to CNS damage and alteration of BBB integrity in the absence of SARS-CoV-2 RNA detection in CSF or blood. CNS damage was still detectable after discharge in blood of COVID-19 patients who developed ARDS during hospitalization.
2022
mmps; nfL; ddpcr; long-covid; matrix metalloproteinases; neuro-covid; neurofilament light chain; zymography; axons; humans; rna, viral; sars-cov-2; blood-brain barrier; covid-19
01 Pubblicazione su rivista::01a Articolo in rivista
Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients / Zingaropoli, Maria Antonella; Iannetta, Marco; Piermatteo, Lorenzo; Pasculli, Patrizia; Latronico, Tiziana; Mazzuti, Laura; Campogiani, Laura; Duca, Leonardo; Ferraguti, Giampiero; De Michele, Manuela; Galardo, Gioacchino; Pugliese, Francesco; Antonelli, Guido; Andreoni, Massimo; Sarmati, Loredana; Lichtner, Miriam; Turriziani, Ombretta; Ceccherini-Silberstein, Francesca; Liuzzi, Grazia Maria; Mastroianni, Claudio Maria; Ciardi, Maria Rosa. - In: CELLS. - ISSN 2073-4409. - 11:16(2022), pp. 1-18. [10.3390/cells11162480]
File allegati a questo prodotto
File Dimensione Formato  
Zingaropoli_Neuro-Axonal-Damage_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.46 MB
Formato Adobe PDF
2.46 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1655053
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 11
social impact